tirzepatide osa fda approval approves weight-loss drug Zepbound to treat sleep apnea FDA's First GLP-1 Approval for

Mean glucose, standard deviation and GRI also showed greater improvement with AID in the type 1 diabetes group

Your provider will help you transition to a maintenance plan, which may include a lower medication dose or continued lifestyle coaching

The safety pool included data from the 24-week treatment and 12-week follow-up periods from both trials

As of January 2026, 13 states cover tirzepatide and other GLP-1 medications for weight loss

Soto can put the finishing touches on your slimmer physique with surgical procedures including: Find out which body contouring treatments may best suit your needs based on the amount of weight youve lost and other factors